LB Pharmaceuticals adopts amended charter and bylaws upon IPO closing on Sept 12, 2025

LB PHARMACEUTICALS INC

Filed amended and restated certificate of incorporation with Delaware Secretary of State.
Adopted amended and restated bylaws effective immediately prior to IPO closing.
Both documents previously approved by board and stockholders.
IPO closed on September 12, 2025; common stock trades on Nasdaq under LBRX.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

LB PHARMACEUTICALS INC: Filed amended and restated certificate of incorporation effective upon closing of IPO (effective 2025-09-12).

Change: charter amendment
Effective: 2025-09-12

Exact text from the filing

the Company filed an amended and restated certificate of incorporation (the “ Restated Certificate ”) with the Secretary of State of the State of Delaware

View on SEC.gov

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

LB PHARMACEUTICALS INC: Adopted amended and restated bylaws effective upon closing of IPO (effective 2025-09-12).

Change: bylaw amendment
Effective: 2025-09-12

Exact text from the filing

Effective as of September 12, 2025, the Company adopted amended and restated bylaws (the “ Restated Bylaws ”) in connection with the closing of the IPO

View on SEC.gov

89 governance changes filed in the last 30 days. Browse all governance changes →

LB PHARMACEUTICALS INC filing history →

Source: SEC EDGAR

accession 0001193125-25-202195

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.